G Scott Gazelle

Author PubWeight™ 121.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003 5.42
2 Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 2012 4.72
3 Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 2004 4.36
4 American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013 3.16
5 Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol 2006 2.88
6 Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011 2.83
7 Paraesophageal hernias: operation or observation? Ann Surg 2002 2.71
8 Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 2004 2.53
9 Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008 2.37
10 Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst 2012 2.30
11 Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg 2006 2.25
12 Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003 2.22
13 Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2008 1.57
14 Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol 2011 1.56
15 Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med 2012 1.52
16 Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making 2004 1.51
17 Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics 2009 1.48
18 Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol 2008 1.42
19 Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol 2008 1.37
20 A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail 2006 1.36
21 Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol 2009 1.34
22 Calibration of disease simulation model using an engineering approach. Value Health 2009 1.27
23 Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer 2008 1.26
24 Cost-effectiveness of whole-body CT screening. Radiology 2005 1.25
25 Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health 2008 1.24
26 Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health 2011 1.22
27 Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making 2006 1.14
28 Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 2002 1.14
29 Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology 2008 1.13
30 Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 2014 1.13
31 Diagnostic imaging costs: are they driving up the costs of hospital care? Radiology 2005 1.11
32 Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation 2005 1.11
33 Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002 1.11
34 Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology 2010 1.09
35 Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol 2007 1.09
36 Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology 2010 1.07
37 Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 2003 1.07
38 Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal 2012 1.05
39 Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology 2008 1.04
40 Elective endovascular versus open surgical repair of abdominal aortic aneurysms: systematic review of short-term results. Radiology 2002 1.03
41 Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol 2004 1.03
42 The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol 2007 0.99
43 Abdominal and pelvic computed tomography (CT) interpretation: discrepancy rates among experienced radiologists. Eur Radiol 2010 0.98
44 Falling prey to the sunk cost bias: a potential harm of patient radiation dose histories. Radiology 2012 0.97
45 An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology 2004 0.96
46 Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 2011 0.95
47 Improved coagulation with saline solution pretreatment during radiofrequency tumor ablation in a canine model. J Vasc Interv Radiol 2002 0.95
48 Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer 2011 0.94
49 Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology 2003 0.94
50 Cost-effectiveness of PET in the diagnosis of Alzheimer disease. Radiology 2003 0.93
51 Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) 2009 0.93
52 Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Ann Pharmacother 2006 0.93
53 Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 2004 0.92
54 Appropriateness and utilization of cardiac CT: implications for development of future criteria. J Nucl Cardiol 2010 0.91
55 The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev 2011 0.91
56 Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer 2012 0.90
57 CT screening: a trade-off of risks, benefits, and costs. J Clin Invest 2003 0.89
58 Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci 2009 0.87
59 Biomedical Imaging Research Opportunities Workshop: report and recommendations. Radiology 2003 0.87
60 Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One 2010 0.87
61 Radiologist report turnaround time: impact of pay-for-performance measures. AJR Am J Roentgenol 2010 0.86
62 The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer 2004 0.86
63 Comparative effectiveness research: what it means for radiology. Radiology 2009 0.86
64 Medicare's national coverage decisions, 1999-2003: quality of evidence and review times. Health Aff (Millwood) 2005 0.86
65 Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci 2005 0.85
66 Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox. Radiology 2012 0.85
67 MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol 2014 0.85
68 MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR Am J Roentgenol 2009 0.84
69 Assessment and validation of imaging methods and technologies. Acad Radiol 2003 0.84
70 Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes 2006 0.84
71 Journal club: How radiation exposure histories influence physician imaging decisions: a multicenter radiologist survey study. AJR Am J Roentgenol 2013 0.83
72 Decision support for radiologist report recommendations. J Am Coll Radiol 2011 0.83
73 Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication. Med Decis Making 2002 0.83
74 Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure. Eur J Heart Fail 2008 0.83
75 Decision-analytic models to simulate health outcomes and costs in heart failure: a systematic review. Pharmacoeconomics 2011 0.83
76 Assessing the comparative effectiveness of a diagnostic technology: CT colonography. Health Aff (Millwood) 2008 0.82
77 Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol 2002 0.81
78 Exploring the impact of language services on utilization and clinical outcomes for diabetics. PLoS One 2012 0.81
79 Use of imaging in the emergency department: physicians have limited effect on variation. Radiology 2013 0.81
80 Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer. J Thorac Oncol 2015 0.81
81 Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections. Radiology 2012 0.81
82 Cost of an informatics-based diabetes management program. Int J Technol Assess Health Care 2006 0.81
83 Abdominal aortic aneurysms: cost-effectiveness of elective endovascular and open surgical repair. Radiology 2002 0.80
84 Medical device specificities: opportunities for a dedicated product development methodology. Expert Rev Med Devices 2012 0.80
85 Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk. Acad Radiol 2009 0.79
86 Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol 2010 0.79
87 Perceived usefulness of cardiac computed tomography as assessed by referring physicians and its effect on patient management. Am J Cardiol 2010 0.79
88 Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department. Am J Cardiol 2006 0.79
89 Biomedical Imaging Research Opportunities Workshop III: a white paper. Ann Biomed Eng 2006 0.78
90 A framework to identify the costs of providing language interpretation services. J Health Care Poor Underserved 2011 0.78
91 A simulation model of clinical and economic outcomes of cardiac CT triage of patients with acute chest pain in the emergency department. AJR Am J Roentgenol 2011 0.78
92 Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol 2013 0.78
93 Cost-effectiveness targets for multi-detector row CT angiography in the work-up of patients with intermittent claudication. Radiology 2003 0.78
94 Probability in radiology. Radiology 2003 0.77
95 Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model. AJR Am J Roentgenol 2009 0.77
96 Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer 2015 0.77
97 Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis. J Vasc Interv Radiol 2003 0.77
98 Modeling of the medical device development process. Expert Rev Med Devices 2012 0.77
99 Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening. Pancreas 2016 0.76
100 Biomedical Imaging Research Opportunities Workshop II: report and recommendations. Radiology 2005 0.76
101 Two schedules of second-line irinotecan for metastatic colon carcinoma. Cancer 2004 0.76
102 Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci 2008 0.75
103 Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2009 0.75
104 Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Acad Radiol 2012 0.75
105 The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography. Clin Gastroenterol Hepatol 2005 0.75
106 Enhancing patient safety: standardization of CT contrast media practices. J Am Coll Radiol 2009 0.75
107 Examining the use of comparative and cost-effectiveness analyses in radiology. AJR Am J Roentgenol 2014 0.75
108 Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions. Radiology 2008 0.75
109 A cost-effectiveness analysis of a hypothetical catheter-based strategy for the detection and treatment of vulnerable coronary plaques with drug-eluting stents. J Interv Cardiol 2005 0.75
110 What is digital medicine? Stud Health Technol Inform 2002 0.75
111 Adapting to a new system of surgical technologies and perioperative processes among clinicians. J Surg Res 2007 0.75
112 Deterministic sensitivity analysis for first-order Monte Carlo simulations: a technical note. Value Health 2008 0.75
113 Analysis of aspirin-associated risks in healthy individuals. Ann Pharmacother 2004 0.75